For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
The Nicotinamide Mononucleotide (NMN) market revenue was 191.89 Million USD in 2022, and will reach 296.05 Million USD in 2028, with a CAGR of 7.49% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the Nicotinamide Mononucleotide (NMN) industry, and breaks down according to the type, application, and consumption area of Nicotinamide Mononucleotide (NMN). The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.
In Chapter 2.3 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Nicotinamide Mononucleotide (NMN) in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
Chapter 2.5 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 6-10 consider the impact of COVID-19 on the regional economy.
Key players in the global Nicotinamide Mononucleotide (NMN) market covered in Chapter 11:
Kindomway
MIRAILAB BIOSCIENCE Inc.
Maac10 Formulas
Bontac
CELFULL
Genex Formulas
GeneHarbor
Herbalmax
In Chapter 3, on the basis of types, the Nicotinamide Mononucleotide (NMN) market from 2018 to 2028 is primarily split into:
Content Below 98%
Content Above 98%
In Chapter 4, on the basis of applications, the Nicotinamide Mononucleotide (NMN) market from 2018 to 2028 covers:
Health Care Products
Cosmetics
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2028) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10:
North America (Covered in Chapter 6)
United States
Canada
Mexico
Europe (Covered in Chapter 7)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8)
China
Japan
South Korea
Australia
India
Middle East and Africa (Covered in Chapter 9)
Saudi Arabia
UAE
Egypt
South Africa
South America (Covered in Chapter 10)
Brazil
Argentina
Columbia
Years considered for this report:
Historical Years: 2018-2022
Base Year: 2022
Estimated Year: 2023
Forecast Period: 2023-2028